Medical System Network Co., Ltd. AI Stock Analysis
Want to see JP:4350 full AI Analyst Report?
Medical System Network Co., Ltd. (4350) AI Stock Analysis
Medical System Network Co., Ltd.
(TSE/TYO:4350)
The overall stock score of 52 reflects a mixed fundamental and technical profile. The most significant risks stem from severe recent cash burn and contracting profit margins, which heavily offset the company's strong balance sheet deleveraging and consistent top-line growth. Short-term bearish momentum and a moderate valuation further constrain the score, though an oversold technical signal and a decent dividend yield offer limited support.
Medical System Network Co., Ltd. (4350) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 15.93B
- Dividend Yield
- 2.23%
- Average Volume (3M)
- 100.23K
- Price to Earnings (P/E)
- 23.8
- Beta (1Y)
- 0.29
- Revenue Growth
- 6.89%
- EPS Growth
- -55.21%
- Country
- Japan
- Employees
- 4,014
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Pharmaceuticals
Medical System Network Co., Ltd. Business Overview & Revenue Model
Company Description
Headquartered in Sapporo, Japan, and established in 1999, Medical System Network Co., Ltd. functions as a comprehensive provider within the healthcare industry. Its core business involves the distribution of pharmaceutical products to a diverse range...
Medical System Network Co., Ltd. Financial Statement Overview
Summary
Displays a mixed profile marked by steady revenue growth and significant balance sheet deleveraging, heavily offset by contracting profit margins and a recent steep dive into negative cash flows.
Income Statement
52NeutralBalance Sheet
78PositiveCash Flow
35Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 134.23B | 132.19B | 122.39B | 115.36B | 109.55B | 106.69B |
| Gross Profit | 54.03B | 52.77B | 49.60B | 47.93B | 45.92B | 44.43B |
| EBITDA | 6.28B | 6.73B | 6.42B | 6.90B | 6.25B | 7.05B |
| Net Income | 870.00M | 1.07B | 1.26B | 1.86B | 1.61B | 2.39B |
Balance Sheet | ||||||
| Total Assets | 79.29B | 80.10B | 70.63B | 68.19B | 66.27B | 62.98B |
| Cash, Cash Equivalents and Short-Term Investments | 7.28B | 7.74B | 8.46B | 8.27B | 8.14B | 8.20B |
| Total Debt | 30.51B | 37.67B | 29.79B | 29.18B | 30.52B | 29.57B |
| Total Liabilities | 62.16B | 62.68B | 54.28B | 52.97B | 51.78B | 49.69B |
| Stockholders Equity | 17.00B | 17.29B | 16.26B | 15.17B | 14.45B | 13.27B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -5.93B | 1.75B | 5.62B | 3.37B | 1.88B |
| Operating Cash Flow | 0 | -3.44B | 4.46B | 7.72B | 4.97B | 4.01B |
| Investing Cash Flow | 0 | -4.04B | -3.73B | -3.65B | -2.11B | -2.51B |
| Financing Cash Flow | 0 | 6.79B | -544.00M | -3.94B | -2.92B | -3.42B |
Medical System Network Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4350, the sentiment is Positive. The current price of 537.00 is above the 20-day moving average (MA) of 529.05, above the 50-day MA of 515.86, and above the 200-day MA of 501.19, indicating a bullish trend. The MACD of 0.51 indicates Positive momentum. The RSI at 55.54 is Neutral, neither overbought nor oversold. The STOCH value of 25.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4350.
Medical System Network Co., Ltd. Peers Comparison
Overall Rating
JP:998982Outperform
JP:339181Outperform
JP:764969Neutral
JP:354968Neutral
JP:334959.9Neutral
JP:435052Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 82Outperform | JPY 492.60B | 15.59 | 11.04% | 3.13% | 3.99% | -0.48% | |
| 81Outperform | JPY 1.14T | 19.82 | 7.13% | 1.86% | ― | ― | |
| 69Neutral | JPY 556.91B | 17.58 | 9.94% | 1.22% | 8.97% | -29.54% | |
| 68Neutral | JPY 475.40B | 25.13 | ― | 1.61% | 12.54% | 15.87% | |
| 60Neutral | JPY 509.68B | 15.73 | ― | 1.28% | 8.99% | 3.61% | |
| 52Neutral | JPY 16.21B | 23.78 | ― | 2.23% | 6.89% | -55.21% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4350 | Medical System Network Co., Ltd. | 537.00 | 33.51 | 6.66% | |
| JP:9989 | Sundrug Co | 4213.00 | -68.36 | -1.60% | |
| JP:7649 | Sugi Holdings Co | 1433.00 | -421.06 | -22.71% | |
| JP:3391 | TSURUHA Holdings | 2522.00 | -311.26 | -10.99% | |
| JP:3349 | COSMOS Pharmaceutical Corporation | 6403.00 | -1113.32 | -14.81% | |
| JP:3549 | KUSURI NO AOKI HOLDINGS CO.,LTD. | 4972.00 | 1028.63 | 26.08% |
Medical System Network Co., Ltd. Corporate Events
Medical System Network Reports 4.7% First-Quarter Sales Growth
Medical System Network Co., Ltd. has businesses in the medical field, including community pharmacy, medical support and medical supply, as well as leasing and facilities, meal catering and home-visit nursing. In the first quarter of the fiscal year e...
Medical System Network Reports Six-Month Sales Growth, Profit Declines
Medical System Network Co., Ltd. reported consolidated sales of ¥66,887 million for the six months ended September 30, 2026, up 4.7% year over year. EBITDA fell 21.0% to ¥2,365 million, while operating profit declined 44.7% to ¥710 million, ordinary...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 18, 2026
